Steineger Hilde H 4
4 · Strongbridge Biopharma plc · Filed May 17, 2018
Insider Transaction Report
Form 4
Steineger Hilde H
Director
Transactions
- Award
Stock Options (Right to Buy)
2018-05-15+40,000→ 40,000 totalExercise: $7.75From: 2019-05-15Exp: 2028-05-15→ Common Stock (40,000 underlying)